Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas-Reference-Cited by-同舟云学术

Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas

Published:2006 Issue:5 Volume:107 Page:1014-1022
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Nickenig Christina,Dreyling Martin,Hoster Eva,Pfreundschuh Michael,Trumper Lorenz,Reiser Marcel,Wandt Hannes,Lengfelder Eva,Unterhalt Michael,Hiddemann Wolfgang,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference28 articles.

1. Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group

2. High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS

3. Immunochemotherapy in indolent non-Hodgkin's lymphoma

4. Rituximab Plus Short-Duration Chemotherapy As First-Line Treatment for Follicular Non-Hodgkin’s Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ayurveda Rasayana Therapy (ART) leads to tumor regression and increased survival in chemo‐intolerance high‐grade stage IV follicular lymphoma: A case study;Clinical Case Reports;2024-05-30

2. Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium;Journal of Hematology & Oncology;2023-12-16

3. The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis;Annals of Hematology;2023-08-08

4. Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas;HemaSphere;2022-08-10

5. Hematological Changes Following Low Dose Radiation Therapy and Comparison to Current Standard of Care Cancer Treatments;Dose-Response;2021-10